A 65-year-old woman experienced immediate itchy erythematous patches at the
subcutaneous injection sites of sodium enoxaparin. An erythematous and inf
iltrated 40 x 20 mm lesion on the abdominal wall could be observed at the s
ite of enoxaparin injection when she was referred to our clinic 48 h after
injection. Lesions subsided spontaneously within I week. She had been on th
is treatment 1 and 3 years before without any adverse reaction. To clarify
the nature of the reaction, epicutaneous tests with sodium enoxaparin, calc
ium nadroparin and calcium heparin were performed, all with negative result
s. Skin prick test with sodium enoxaparin was also negative. Biopsy of the
cutaneous lesion showed spongiotic dermatitis, strongly suggesting a delaye
d hypersensitivity mechanism. We report here on a new case of delayed hyper
sensitivity to enoxaparin. Being female, overweight and having prolonged ap
plication of the drug were suggested risk factors present in our patient. B
iopsy was essential for diagnosis. Although type IV hypersensitivity reacti
ons to enoxaparin are rare, we should start to suspect this condition in or
der not to underdiagnose it.